首页> 外国专利> MATERIALS AND METHODS FOR MANAGEMENT OF HYPERACUTE REJECTION IN HUMAN XENOTRANSPLANTATION

MATERIALS AND METHODS FOR MANAGEMENT OF HYPERACUTE REJECTION IN HUMAN XENOTRANSPLANTATION

机译:人异种移植术中大面积排斥反应管理的材料和方法

摘要

Human pre-formed xenoatibodies play an important role in the hyperacute rejection response response in human xenotransplantation. Disclosedare materials and methods for removing or neutralizing such antibodies. Also disclosed are materials and methods for reducing or eliminatingthe epitopes in the donor organs that are recognized by such antibodies. Such epitopes are formed as the result of activity by the enzyme .alpha.-1,3 galactosyltransferase. The porcine gene encoding .alpha.- 1,3 galactosy transferase is disclosed, as are materials and methods for inactivating("knocking out") the .alpha.-1,3 galactosyltransferase gene in mammalian cells and embryos. Included are nucleic acid constructs useful forinactivating the .alpha.-1,3 galactosyltransferase gene in a target cell .Also disclosed is a novel leukemia inhibitory factor (T-LIF) that is usefulfor maintenance of embryonic stem cells and primordial germ cells in culture.
机译:人类预先形成的异种抗体在人类异种移植的超急性排斥反应中起重要作用。已公开是用于去除或中和此类抗体的材料和方法。还公开了用于减少或消除的材料和方法被这些抗体识别的供体器官中的表位。这种表位是由α-酶的活性形成的。1,3半乳糖基转移酶。公开了编码α-1,3半乳糖转移酶的猪基因,以及用于灭活的材料和方法。(“敲除”)哺乳动物细胞和胚胎中的α-1,3半乳糖基转移酶基因。包括可用于使靶细胞中的α-1,3半乳糖基转移酶基因失活。还公开了一种新型的白血病抑制因子(T-LIF)用于维持培养中的胚胎干细胞和原始生殖细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号